Drreddys Laboratories reported INR85.45B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
ANI Pharmaceuticals USD 211.37M 14.27M Jun/2025
Aurora Cannabis CAD 98.02M 9.82M Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Canopy Growth CAD 72.13M 2.63M Jun/2025
Cipla INR 69.57B 2.27B Jun/2025
Corcept Therapeutics USD 194.4M 37.2M Jun/2025
Drreddys Laboratories INR 85.45B 1.87B Jun/2025
GlaxoSmithKline GBP 7.99B 470M Jun/2025
Hikma Pharmaceutical USD 1.59B 18M Dec/2024
Lonza CHF 3.58B 63M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Pacira USD 181.1M 12.18M Jun/2025
Prestige Brands USD 249.53M 46.99M Jun/2025
Richter Gedeon HUF 216.73B 469M Sep/2024
Sun Pharmaceuticals INR 138.51B 8.92B Jun/2025
Supernus Pharmaceuticals USD 165.5M 15.7M Jun/2025
Teva Pharmaceutical Industries USD 14.06B 0 Jun/2025